QP 24 - Radiation and Cancer Biology 7: Tumor Immune Interactions

Presentations

• 10:30am - 10:35am PT

  Introduction

  Speaker: Jie Deng, MD, PhD - UCLA Radiation Oncology, Los Angeles
• 10:35am - 10:40am PT

  ADAR1 Expression in CD8⁺ T Cells Modulates Radiotherapy Response and Prognosis in Non-Small Cell Lung Cancer via Disrupting Mitochondrial Function

  Speaker: Chen Tian, PhD - Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan
• 10:40am - 10:45am PT

  Tumor Immune Microenvironment Modulation by Single-Fraction vs. Multifraction SBRT in an Orthotopic NSCLC Mouse Model

  Speaker: Lea Bouchard, MD, MS - University of Sherbrooke, Sherbrooke
• 10:45am - 10:50am PT

  hnRNPA1 Impedes the Anti-Tumor Immune Response Effect via Competitively Inhibiting TRIM21-Mediated Ubiquitination and Degradation of CD155

  Speaker: Lu Zhang, MS, none - Chongqing University Cancer Hospital, Shapingba
• 10:50am - 10:55am PT

  Conventional Fractionated Elective Nodal Irradiation Preserves Early Antitumor Immunity and Efficacy Compared to Hypofractionated Protocols

  Speaker: Genki Sato, MD - Kyoto University Hospital, Kyoto
• 10:55am - 11:00am PT

  Focal Adhesion Kinase Targeting Enhances Anti-Tumor Immunity Following Conventionally Fractionated Radiation

  Speaker: Brian Leibowitz, PhD - University of Pittsburgh School of Medicine, Pittsburgh
• 11:00am - 11:05am PT

  Quantifying Pan-Cancer Immune Temperature to Predict Patient-Specific Radiation Response and Outcome

  Speaker: Awino Maureiq Ojwang', PhD - MD Anderson Cancer Center, Houston
• 11:05am - 11:10am PT

  Question and Answers

  Speaker: Gregory Gan, MD, PhD - KUMC, Kansas city
• 11:10am - 11:30am PT

  Closing

  Speaker: Jie Deng, MD, PhD - UCLA Radiation Oncology, Los Angeles